Basal-Type Breast Cancer Prognosis and Characteristics

Definition and Distinction

The American Joint Committee on Cancer and other guideline societies distinguish basal-like breast cancer from triple-negative breast cancer (TNBC), although they overlap substantially, with approximately 75% of TNBC cases being basal-like, and 25% not being basal-like 1, 2, 3, 4, 5
Basal-like tumors are defined by ER-negative, PR-negative, HER2-negative status PLUS positive expression of basal markers (cytokeratin 5/6 and/or EGFR), whereas triple-negative tumors lack these three receptors but may not express basal markers 1, 2, 3, 4

Basal-like tumors demonstrate significantly higher combined grade compared to luminal A tumors (OR = 8.3, 95% CI 4.4–15.6), and exhibit higher mitotic index (OR = 11.0, 95% CI 5.6–21.7) and more marked nuclear pleomorphism (OR = 9.7, 95% CI 5.3–18.0) 4, 5, 6
In African populations, 83% of basal-like tumors presented as high-grade 7
The 5-year survival rate for African-American women with late-stage TNBC/basal-like disease is only 14% 5, 6

Peak recurrence risk for basal-like tumors occurs within 3 years, with increased mortality for 5 years post-diagnosis 8
The European Society of Medical Oncology and other guideline societies note that the poor prognosis associated with basal-like breast cancer is not uniform across all presentations, with high-grade tumors having particularly aggressive behavior 5, 6